BlackRock Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

BlackRock Investment Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.25M	Sell	91,906 -405	-0.4%	-$5.65K	﹤0.01%	2552
2016 Q3	$1.14M	Sell	92,311 -136	-0.1%	-$1.6K	﹤0.01%	2584
2016 Q2	$1.01M	Buy	92,447 +3,032	+3%	+$33.9K	﹤0.01%	2626
2016 Q1	$977K	Buy	89,415 +209	+0.2%	+$2.64K	﹤0.01%	2504
2015 Q4	$1.54M	Buy	89,206 +540	+0.6%	+$9.68K	﹤0.01%	2266
2015 Q3	$1.76M	Sell	88,666 -1,346	-1%	-$30.9K	﹤0.01%	2162
2015 Q2	$1.48M	Buy	90,012 +38,294	+74%	+$664K	﹤0.01%	2472
2015 Q1	$805K	Buy	51,718 +436	+0.9%	+$6.76K	﹤0.01%	2667
2014 Q4	$732K	Sell	51,282 -523	-1%	-$5.52K	﹤0.01%	2761
2014 Q3	$337K	Buy	51,805 +2,041	+4%	+$13.6K	﹤0.01%	3146
2014 Q2	$343K	Buy	49,764 +12,057	+32%	+$85.3K	﹤0.01%	3167
2014 Q1	$270K	Sell	37,707 -436	-1%	-$3.73K	﹤0.01%	3189
2013 Q4	$359K	Sell	38,143 -357	-0.9%	-$2.55K	﹤0.01%	3102
2013 Q3	$240K	Buy	38,500 +3,617	+10%	+$22.6K	﹤0.01%	3156
2013 Q2	$230K	Buy	+34,883	New	+$277K	﹤0.01%	3140

Other funds holding SCMP

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return

BlackRock Investment Management's SCMP Position: Q4 2016 in Review

BlackRock Investment Management reduced its Sucampo Pharmaceuticals, Inc. (SCMP) stake by 0.44% in Q4 2016, selling an estimated $5.65K and leaving 91,906 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2552.

BlackRock Investment Management first reported a position in SCMP in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.76M in Q3 2015. 165 funds tracked by Wall St. Rank hold SCMP as of Q4 2016.

BlackRock Investment Management held 91,906 shares of Sucampo Pharmaceuticals, Inc. worth $1.25M as of Q4 2016.
BlackRock Investment Management sold 405 Sucampo Pharmaceuticals, Inc. shares in Q4 2016, an estimated $5.65K.
Sucampo Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2552 holding.
BlackRock Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $1.76M in Q3 2015.
165 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.